Aptamer-engineered extended-gate field-effect transistor device for point-of-care therapeutic drug monitoring

Analyst. 2022 Oct 10;147(20):4413-4416. doi: 10.1039/d2an01393b.

Abstract

Herein, we report a portable point-of-care testing (POCT) device based on an aptamer-engineered extended-gate field-effect transistor (EG-FET) for therapeutic monitoring of the drug methotrexate. This method was shown to be highly sensitive, efficient, and convenient to use, features contributing to its realizing a clinical detection of drugs in blood.

MeSH terms

  • Biosensing Techniques* / methods
  • Drug Monitoring
  • Methotrexate
  • Oligonucleotides
  • Point-of-Care Systems

Substances

  • Oligonucleotides
  • Methotrexate